Bethany Sensenig Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

Bethany Sensenig is Director of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 5,369 shares of SUPN, which is worth approximately $167,351. The most recent transaction as insider was on Feb 22, 2025, when has been sold 5,369 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.37K

n/a 3M change

n/a 12M change

Total Value Held $167,351

Bethany Sensenig Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 22 2025	BUY Grant, award, or other acquisition	-	5,369 Added 50.0%	5,369 Common Stock

Also insider at

NMTR

9 METERS BIOPHARMA, INC. Healthcare

Chief Financial Officer